Related Experiment Videos
Vitamin D regulation of metalloproteinase activity in matrix vesicles
D D Dean1, Z Schwartz, J Schmitz
1Department of Orthopaedics, University of Texas Health Science Center, San Antonio 78284, USA.
Abstract:
Matrix vesicles (MVs) are enriched in matrix metalloproteinases (MMPs) capable of degrading proteoglycans. The aim of the present study was to identify which MMPs are present in MVs and determine whether these MMPs are regulated by 1,25-(OH)2D3 [1,25] and 24,25-(OH)2D3 [24,25]. To do this, growth zone (GC) and resting zone (RC) chondrocytes were isolated from rate costochondral cartilage and placed into culture. At confluence, GCs were treated with 1,25 and RCs with 24,25 for 24 hours. MVs, plasma membranes (PMs), and conditioned media were then collected from the cultures. RTPCR demonstrated the presence of mRNA for stromelysin-1 and 72 kDa gelatinase in both RCs and GCs, Casein zymography revealed activity at M(r) 48 and 28 kDa in MV, but not PM or conditioned media; Western analysis confirmed that this activity was stromelysin-1. Gelatinolytic activity, at low levels, was also found in MVs, but not PMs or conditioned media. When enzyme activity was measured using a proteoglycan bead assay, it was found that both GCs and RCs produced MVs and PMs containing neutral metalloproteinase. Both cells also produced MVs and PMs containing plasminogen activator. The addition of 1,25 to GCs caused a significant 4- to 5-fold increase in metalloproteinase activity in MVs, but not PMs. In contrast, MVs from cultures of RCs treated with 24,25 contained decreased metalloproteinase activity; enzyme activity in PMs was unaffected by 24,25. Plasminogen activator in MVs from RC was increased by treatment with 24,25, while MV enzyme activity was decreased after treatment of GC cultures with 1,25. This study shows that both RCs and GCs produce stromelysin-1 and 72 kDa gelatinase and that these enzymes are preferentially localized in MVs. Further, MMP and plasminogen activator activities in MVs and PMs are regulated by vitamin D metabolites.
Insights
Matrix vesicles contain specific matrix metalloproteinases (MMPs) that degrade proteoglycans. Vitamin D metabolites, 1,25-(OH)2D3 and 24,25-(OH)2D3, regulate MMP activity in these vesicles, impacting cartilage health.
Area of Science:
- Biochemistry
- Cell Biology
- Biomineralization
Background:
- Matrix vesicles (MVs) are crucial for cartilage mineralization and contain enzymes like matrix metalloproteinases (MMPs).
- Proteoglycan degradation by MMPs plays a role in cartilage homeostasis and disease.
- The influence of vitamin D metabolites on MV enzyme activity is not fully understood.
Purpose of the Study:
- To identify specific MMPs within MVs.
- To investigate the regulatory effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on MMPs in MVs.
- To determine the localization of these enzymes in MVs versus plasma membranes.
Main Methods:
- Isolation of growth zone (GC) and resting zone (RC) chondrocytes from cartilage.
- Culture of chondrocytes and treatment with 1,25-(OH)2D3 (GCs) or 24,25-(OH)2D3 (RCs).
- Collection and analysis of MVs, plasma membranes (PMs), and conditioned media using RT-PCR, casein zymography, Western analysis, and proteoglycan bead assays.
Main Results:
- Stromelysin-1 and 72 kDa gelatinase mRNA were detected in both RC and GC chondrocytes.
- Casein zymography and Western analysis confirmed stromelysin-1 activity predominantly in MVs.
- 1,25-(OH)2D3 significantly increased metalloproteinase activity in GC-derived MVs, while 24,25-(OH)2D3 decreased it in RC-derived MVs.
Conclusions:
- Both resting and growth zone chondrocytes produce stromelysin-1 and 72 kDa gelatinase, primarily localized in matrix vesicles.
- Vitamin D metabolites differentially regulate metalloproteinase and plasminogen activator activities within MVs.
- These findings highlight a novel role for vitamin D in modulating cartilage matrix metabolism via matrix vesicles.